227 related articles for article (PubMed ID: 37395104)
1. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
3. New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review.
Benini V; Ruffolo AF; Casiraghi A; Degliuomini RS; Frigerio M; Braga A; Serati M; Torella M; Candiani M; Salvatore S
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744033
[TBL] [Abstract][Full Text] [Related]
4. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
[TBL] [Abstract][Full Text] [Related]
5. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
[TBL] [Abstract][Full Text] [Related]
6. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
7. Review of non-invasive vulvovaginal rejuvenation.
Photiou L; Lin MJ; Dubin DP; Lenskaya V; Khorasani H
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):716-726. PubMed ID: 31714632
[TBL] [Abstract][Full Text] [Related]
8. 'Vaginal Laser Therapy for GSM/VVA: Where We Stand Now - A Review by the EUGA Working Group on Laser'.
Li FG; Abbott JA
Climacteric; 2023 Dec; 26(6):638. PubMed ID: 37782251
[No Abstract] [Full Text] [Related]
9. Vaginal Laser Treatment for the Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Narrative Review.
Okui N
Cureus; 2023 Sep; 15(9):e45495. PubMed ID: 37731685
[TBL] [Abstract][Full Text] [Related]
10. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive treatment of vulvovaginal atrophy in menopause with CO2 laser.
D'Oria O; Giannini A; Prata G; Scudo M; Logoteta A; Mondo A; Perniola G; Palaia I; Cascialli G; Monti M; Muzii L; Benedetti Panici P; DI Donato V
Minerva Obstet Gynecol; 2021 Apr; 73(2):127-134. PubMed ID: 32720802
[TBL] [Abstract][Full Text] [Related]
12. Laser Therapy for Genitourinary Syndrome of Menopause.
Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of non-ablative CO
Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
15. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G
Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595
[TBL] [Abstract][Full Text] [Related]
16. Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study.
Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; Giuliano M; Lauria R; De Santo I; Conforti A; Gallo A; Nazzaro G; De Placido S; Locci M; De Placido G
Menopause; 2018 Jun; 25(6):657-662. PubMed ID: 29286986
[TBL] [Abstract][Full Text] [Related]
17. Laser therapy for the restoration of vaginal function.
Gambacciani M; Palacios S
Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
[TBL] [Abstract][Full Text] [Related]
18. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
The NAMS 2020 GSM Position Statement Editorial Panel
Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
[TBL] [Abstract][Full Text] [Related]
19. [Short-term efficacy of vaginal CO
Kozma B; Póka R; Sipos A; Ács N; Takács P
Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
[TBL] [Abstract][Full Text] [Related]
20. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]